apl. Prof. Dr. Udo Gaipl



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells (2022) Stoll E, Hader M, Rückert M, Weissmann T, Lettmaier S, Putz F, Hecht M, et al. Journal article Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines (2022) Schatz J, Ladinig A, Fietkau R, Putz F, Gaipl U, Frey B, Derer A Journal article Orofacial clefts lead to increased pro-inflammatory cytokine levels on neonatal oral mucosa (2022) Seidel CL, Percivalle E, Tschaftari M, Weider M, Strobel K, Willershausen I, Unertl C, et al. Journal article IDENTIFICATION AND CHARACTERIZATION OF CIRCULAR RNAS AS NOVEL PUTATIVE BIOMARKERS TO PREDICT THE SURVIVAL BENEFIT AMONG METASTATIC MELANOMA PATIENTS TREATED WITH ANTI-PD-1 MONOTHERAPY (2022) Zhou JG, Gaipl U, Ma H, Wang H Conference contribution Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy (2022) Hecht M, Eckstein M, Kallies A, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution, Abstract of a poster Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells (2022) Poczta A, Krzeczynski P, Ionov M, Rogalska A, Gaipl U, Marczak A, Lubgan D Journal article Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts (2022) Scheper J, Hildebrand L, Faulhaber EM, Deloch L, Gaipl U, Symank JA, Fietkau R, et al. Journal article Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer (2022) Beck M, Semrau S, Haderlein M, Gostian AO, Hartwich J, Müller SK, Kallies A, et al. Journal article Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials (2022) Zhou JG, Wong AHH, Wang H, Jin SH, Tan F, Chen YZ, He SS, et al. Journal article Identification of an endogenous retroviral signature to predict anti-PD1 response in advanced clear cell renal cell carcinoma: an integrated analysis of three clinical trials (2022) Zhou J, Zeng Y, Wang H, Jin SH, Wang YJ, He S, Frey B, et al. Journal article